daftar pustakarepository.unair.ac.id/86878/3/dis. k. 26-19 dew p daftar...152 daftar pustaka abebe...

152

DAFTAR PUSTAKA

Abebe F, Belay M, Legesse M, K.L.M.C F, Ottenhoff THM. 2018. IgA and IgG against

Mycobacterium tuberculosis Rv2031 discriminate between pulmonary

tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected

individuals. Plos One. vol. 13. no. 1. pp. e0190989.

Achkar JM, Chan J, Casadevall A. 2015. B cells and antibodies in the defense against

Mycobacterium tuberculosis infection. Immunological Reviews. vol. 264. pp. 167-

181.

Adjemian J, Frankland TB, Daida YG, Honda JR, Olivier KN, Zelazny A, Honda S,

Prevots DR. 2017. Epidemiology of nontuberculous mycobacterial lung disease

and tuberculosis, Hawaii, USA. Emerging Infectious Diseases. vol. 23. no. 3. pp.

439-447.

Ahmad F, Zubair S, Gupta P, Gupta UD, Patel R, Owais M. 2017. Evaluation of

aggregated Ag85B antigen for its biophysical properties, immunogenicity, and

vaccination potential in a murine model of tuberculosis infection. Frontiers in

Immunology. vol. 8. pp. 1608.

Applied Biosystems. 2009. DNA sequencing by capillary electrophoresis applied

biosystems chemistry guide second edition. Applied Biosystems. US. diakses 18

April 2016.

https://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/gener

aldocuments/cms_041003.pdf.

Aston SJ, Ho A, Jary H, Huwa J, Mitchell T, Ibitoye S, Greenwood S, Joekes E, Daire

A, Mallewa J, Everett D, Nyirenda M, Faragher B, Mwandumba HC, Heyderman

RS, Gordon SB. 2019. Aetiology and risk factors for mortality in an adult

community-acquired pneumonia cohort in Malawi. American Journal of

Respiratory and Critical Care Medicine. doi: 10.1164/rccm.201807-1333OC. (In

Press).

Babaki MKZ, Soleimanpour S, Rezaee SA. 2017. Antigen 85 complex as a powerful

Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity,

applications in diagnosis, and vaccine design. Microbial Pathogenesis. vol. 112.

pp. 20-29.

Beamer GL, Cyktor J, Flaherty DK, Stromberg PC, Bridget C, Turner J. 2012.

Mycobacterium tuberculosis infected CBA/J mice can generate robust and

protective responses to antigen Ag85 when delivered as a soluble protein, but fail

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA

DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI

https://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_041003.pdfhttps://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_041003.pdf

153

to respond efficiently in the context of natural infection. European Journal of

Immunology. vol. 42. no. 4. pp. 870-879.

Belay M, Legesse M, Mihret A, Ottenhoff THM, Franken KL, Bjune G, Abebe F. 2016.

IFN-g and IgA against non-methylated heparin-binding hemagglutinin as markers

of protective immunity and latent tuberculosis: results of a longitudinal study from

an endemic setting. Journal of Infection. vol. 72. pp. 189-200.

Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. 1997. Role of

the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science.

vol. 276. pp. 1420-1422.

Berkowitz N, Okorie A, Goliath R, Levitt N, Wilkinson RJ, Oni T. 2018. The

prevalence and determinants of active tuberculosis among diabetes patients in

Cape Town, South Africa, a high HIV/TB burden setting. Diabetes Research and

Clinical Practice. vol. 138. pp. 16-25.

Bhunia SK, Sarkar M, Banerjee A, Giri B. 2015. An update on pathogenesis and

management of tuberculosis with special reference to drug resistant. Asian Pacific

Journal of Tropical Disease. vol. 5. no. 9. pp. 673-686.

Biofeng. 2013. pET-SUMO. Biofeng. China. diakses 4 Mei 2018.

http://www.biofeng.com/zaiti/dachang/pET-SUMO.html

Brown TA. 2010. Gene cloning and DNA analysis an introduction sixth edition. John

Wiley &Sons Ltd. UK.

Brown TA. 2016. Gene cloning and DNA analysis an introduction seventh edition.

John Wiley &Sons Ltd. UK.

Burmester È and Pezzutto A. 2003. Color atlas of immunology. Thieme. New York.

Carroll KC, Hobden JA, Miller S, Morse SA, Mietzner TA, Detrick B, Mitchell TG,

McKerrow JH, Sakanari JA. 2016. Jawetz, melnick & adelberg’s medical

microbiology 27th edition. McGraw-Hill Companies Inc. USA.

Cerqueira-Rodrigues B, Mendes A, Correia-Neves M, Nobrega C. 2018. Ag85-focused

T-cell immune response controls Mycobacterium avium chronic infection. Plos

one. vol. 13. no. 3. pp. e0193596.

Chakraborthy A, Shivananjaiah AJ, Ramaswamy S, Chikkavenkatappa N. 2018. Chest

X ray score (Timika score): an useful adjunct to predict treatment outcome in

tuberculosis. Advances in Respiratory Medicine. vol. 86. no. 5. pp. 205-210.



154

Chen JM, Pojer F, Blasco B, Cole ST. 2010. Towards anti-virulence drugs targeting

esx-1 mediated pathogenesis of Mycobacterium tuberculosis, Drug Discovery

Today: Disease Mechanisms. vol. 7. no. 1. pp. 25-31.

Cheng J, Wang L, Zhang H, Xia Y. 2015. Diagnostic value of symptom screening for

pulmonary tuberculosis in China. Plos One. vol. 10. no. 5. pp. e0127725.

Chien JY, Lai CC, Sheng WH, Yu CJ, Hsueh PR. 2014. Pulmonary infection and

colonization with nontuberculous mycobacteria, Taiwan, 2000–2012. Emerging

Infectious Diseases. vol. 20. no. 8. pp. 1382–1385.

Chingonzoh R, Manesen MR, Madlavu MJ, Sopiseka N, Nokwe M, Emwerem M,

Musekiwa A, Kuonza LR. 2018. Risk factors for mortality among adults registered

on the routine drug resistant tuberculosis reporting database in the Eastern Cape

Province, South Africa, 2011 to 2013. Plos One. vol. 13. no. 8. pp. e0202469.

Chuchottaworn C, Thanachartwet V, Sangsayunh P, Than TZM, Sahassananda D,

Surabotsophon M, Desakorn V. 2015. Risk factors for multidrug-resistant

tuberculosis among patients with pulmonary tuberculosis at the central chest

institute of Thailand. Plos One. vol. 10. no. 10. pp. e0139986.

Coico R and Sunshine G. 2015. Immunology: a short course. John Wiley & Sons. West

Sussex

Collins CH, Lyne PM, Grange JM, Falkinham III JO. 2004. Collins and Lyne’s

microbiological methods eighth edition. Arnold. London.

Coppola M, Arroyo L, van Meijgaarden KE, Franken KLMC, Geluk A, Barrera LF,

Ottenhoff THM. 2017. Differences in IgG responses against infection phase

related Mycobacterium tuberculosis (Mtb) specific antigens in individuals

exposed or not to Mtb correlate with control of TB infection and progression.

Tuberculosis. vol. 106. pp. 25-32.

Da Silva PEA and Palomino JC. 2011. Molecular basis and mechanisms of drug

resistance in Mycobacterium tuberculosis: classical and new drugs. Journal of

Antimicrobial Chemotherapy. vol. 66. pp. 1417-1430.

Davila J, Zhang L, Marrs CF, Durmaz R, Yang Z. 2010. Assessment of the genetic

diversity of Mycobacterium tuberculosis esxA,esxH, and fbpB genes among

clinical isolates and its implication for the future immunization by new

tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4. Journal of

Biomedicine and Biotechnology. vol. 2010. pp. 208371.



155

de Araujo LS, da Silva N deBM, Leung JAM, Mello FCQ, Saad MHF. 2018. IgG

subclasses' response to a set of mycobacterial antigens in different stages of

Mycobacterium tuberculosis infection. Tuberculosis. vol. 108. pp. 70-76.

Dembic Z. 2015. The cytokines of the immune system the role of cytokines in disease

related to immune response. Elsevier. United States.

Demir Y and Beydemir S. 2015. Purification, refolding, and characterization of

recombinant human paraoxonase-1. Turkish Journal of Chemistry. vol. 39. pp.

764-776.

Dewi DNSS, Soedarsono, Mertaniasih NM. 2018. T cell epitopes of the esxA full gene

of Mycobacterium tuberculosis from sputum of MDR-TB patients. African

Journal of Infectious Diseases. vol. 12. no. 2. pp. 66-70.

Diaclone. 2018. Instruction for use human IL-7 ELISA set. Diaclone. France. diakses

4 Februari 2019. https://www.diaclone.com/

Dieffenbach CW, Lowe TMJ, Dveksler GS. 1993. General consepts for pcr primer

design. Genome Research. vol. 3. pp. 30-37.

Dinas Kesehatan Jawa Timur. 2017. Profil kesehatan Provinsi Jawa Timur tahun 2016.

Dinas Kesehatan Provinsi Jawa Timur. Surabaya. diakses 4 November 2018.

http://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_

2016/15_Jatim_2016.pdf.

Dinas Kesehatan Kota Surabaya. 2017. Profil kesehatan Kota Surabaya tahun 2016.

Dinas Kesehatan Kota Surabaya. Surabaya. diakses 4 November 2018.

http://www.depkes.go.id/resources/download/profil/PROFIL_KAB_KOTA_201

6/3578_Jatim_Kota_Surabaya_2016.pdf.

Dotulong JFJ, Sapulete MR, Kandou GD. 2015. Hubungan faktor risiko umur, jenis

kelamin dan kepadatan hunian dengan kejadian penyakit TB paru di Desa Wori

Kecamatan Wori. Jurnal Kedokteran Komunitas dan Tropik. vol. III. no. 2. pp.

57-65.

Enos M, Sitienei J, Ong’ang’o J, Mungai B, Kamene M, Wambugu J, Kipruto H,

Manduku V, Mburu J, Nyaboke D, Ngari F, Omesa E, Omale N, Mwirigi N,

Okallo G, Njoroge J, Githiomi M, Mwangi M, Kirathe D, Kiplimo R, Ndombi A,

Odeny L, Mailu E, Kandie T, Maina M, Kasera K, Mulama B, Mugi B, Weyenga

H. 2018. Kenya tuberculosis prevalence survey 2016: challenges and opportunities

of ending TB in Kenya. Plos One. vol. 13. no. 12. pp. e0209098.

Falkinham JO. 1996. Epidemiology of infection by nontuberculous mycobacteria.

Clinical Microbiology Reviews. vol. 9. no. 2. pp. 177-215.



https://www.diaclone.com/http://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_2016/15_Jatim_2016.pdfhttp://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_2016/15_Jatim_2016.pdfhttp://www.depkes.go.id/resources/download/profil/PROFIL_KAB_KOTA_2016/3578_Jatim_Kota_Surabaya_2016.pdfhttp://www.depkes.go.id/resources/download/profil/PROFIL_KAB_KOTA_2016/3578_Jatim_Kota_Surabaya_2016.pdf

156

Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH,

Restrepo BI. 2008. Type 2 diabetes and multi-drug resistant tuberculosis.

Scandinavian Journal of Infectious Disease. vol. 40. no. 11-12. pp. 888-893.

Forrellad MA, Klepp LI, Gioffré A, García JSy, Morbidoni HR, Santangelo MdlP,

Cataldi AA, Bigi F. 2013. Virulence factors of the Mycobacterium tuberculosis

complex. Virulence. vol. 4. no. 1. pp. 3-66.

Franca LTC, Carrilho E, Kist TBL. 2002. A review of DNA sequencing techniques.

Quaterly Reviews of Biophysics. vol. 35. no. 2. pp. 169-200.

Fujita Y, Doi Takeshi, Maekura R, Ito M, Yano I. 2006. Differences in serological

responses to specific glycopeptidolipid-core and common lipid antigens in patients

with pulmonary disease due to Mycobacterium tuberculosis and Mycobacterium

avium complex. Journal of Medical Microbiology. vol. 55. pp. 189-199.

Garibyan L and Avashia N. 2013. Polymerase chain reaction. Journal of Investigative

Dermatology. vol. 133. pp. 1-4.

Gan SD and Patel KR. 2013. Enzyme immunoassay and enzyme-linked

immunosorbent assay. Journal of Investigative Dermatology. vol. 133. pp. e12

Gao J, Zhao L, Wan YY, Zhu B. 2015. Mechanism of Action of IL-7 and Its Potential

Applications and Limitations in Cancer Immunotherapy. International Journal of

Molecular Sciences. vol 16. no. 5. pp. 10267-10280.

Garrity GM, Bell JA, Lilburn TG. 2004. Taxonomic outline of the prokaryotes bergey’s

manual of systematic bacteriology second edition. Springer New York Inc. New

York.

Gennaro ML, Affouf M, Kanaujia GV, Brusasca PN, Mangaura B, Reichman L. 2007.

Antibody markers of incident tuberculosis among HIV-infected adults in the USA:

a historical prospective study. International Journal of Tuberculosis and Lung

Disease. vol. 11. no. 6. pp. 624-631.

Gersh JK, Feldman Z, Greenberger E, Chandra A, Friedman HM, Ho-Foster A, Haas

MK. 2018. Tuberculosis among individuals with community-acquired pneumonia

presenting to emergency in Gaborone, Botswana. Journal of Public Health in

Africa. vol. 9. no. 1. pp. 803.

Ghazawi FM, Faller EM, Sugden SM, Kakal JA, MacPherson PA. 2013. IL-7

downregulates IL-7Rα expression in human CD8 T cells by two independent

mechanisms. Immunology and Cell Biology. vol. 91. no. 2. pp. 149-158.



157

Green DA, Whittier S, Greendyke W, Win C, Chen X, Hamele-Bena D. 2016. Outbreak

of rapidly growing Nontuberculous Mycobacteria among patients undergoing

cosmetic surgery in the Dominican Republic. Annals of Plastic Surgery. vol. 78.

no. 1. pp. 17-21.

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland

SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von

Reyn CF, Wallace RJ, Winthrop K. 2007. An official ATS/IDSA statement:

diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

American Journal of Respiratory and Critical Care Medicine. vol. 175. no. 4. pp.

367-416.

Griffith DE. 2019. Nontuberculous mycobacterial disease, a comprehensive approach

to diagnosis and management. Springer Nature Switzerland AG. Switzerland.

Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, Lewinsohn DM, Smith S,

Sherman DR. 2004. Individual RD1-region genes are required for export of

ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Molecular

Microbiology. vol. 51. no. 2. pp. 359-370.

Gumilar G, Supriyanti FMT, Siti HH. 2008. Bioteknologi modul. FPMIPA Universitas

Pendidikan Indonesia. Bandung.

Gupta RS, Lo B, Son J. 2018. Phylogenomics and comparative genomic studies

robustly support division of the genus Mycobacterium into an emended genus

Mycobacterium and four novel genera. Frontiers in Microbiology. vol. 9. pp. 67.

Hafez SA, Elhefnawy AM, Hatata EA, El Ganady AA, Ibrahiem MI. 2013. Detection

of extensively drug resistant pulmonary tuberculosis. Egyptian Journal of Chest

Diseases and Tuberculosis. vol. 62. no. 4. pp. 635-646.

Hasan NA, Epperson LE, Lawsin A, Rodger RR, Perkins KM, Halpin AL, Perry KA,

Moulton-Meissner H, Diekema DJ, Crist MB, Perz JF, Salfinger M, Daley CL,

Strong M. 2019. Genomic analysis of cardiac surgery–associated Mycobacterium

chimaera Infections, United States. Emerging Infectious Diseases. vol. 25. no. 3.

pp. 559-563.

Hatano S, Tamura T, Umemura M, Matsuzaki G, Ohara N, Yoshikai Y. 2016.

Recombinant Mycobacterium bovis bacillus Calmette–Guérin expressing Ag85B-

IL-7 fusion protein enhances IL-17A-producing innate γδ T cells. Vaccine. vol.

34. no. 22. pp. 2490-2495

Hemmati M, Seghatoleslam A, Rasti M, Ebadat S, Mosavari N, Habibagahi M, Taheri

M, Sardarian AR, Mostafavi-Pour Z. 2011. Expression and purification of

recombinant Mycobacterium tuberculosis (TB) antigens, ESAT-6, CFP-10 and



158

ESAT- 6/CFP-10 and their diagnosis potential for detection of TB Patients. Iran

Red Crescent Medical Journal. vol. 13. no. 8. pp. 556–563.

Hertz D and Schneider B. 2018. Sex differences in tuberculosis. Seminars in

Immunopathology. vol. 41. no. 2. pp. 225-237.

Hiza H, Fenner L, Hela J, Kuchaka D, Sasamalo M, Blauenfeldt T, Kibiki G, Kavishe

RA, Mhimbira F, Ruhwald M. 2018. Boosting effect of IL-7 in interferon gamma

release assays to diagnose Mycobacterium tuberculosis infection. PLoS One. vol.

13. no. 8. pp. e0202525.

Holmberg V, Soini H, Kivelä P, Ollgren J, Ristola M. 2019. Epidemiology and

outcome of HIV patients in Finland co-infected with tuberculosis 1998–2015.

BMC Infectious Diseases. vol. 19. pp. 264.

Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL. 2016. Sex

differences in tuberculosis burden and notifications in low- and middle-income

countries: a systematic review and meta-analysis. Plos Medicine. vol. 13. no. 9.

pp. e1002119.

Howe C. 2007. Gene cloning and manipulation. Cambridge University Press. New

York.

Huang T, Wu K, Yuan X, Shao S, Wang WY, Wei S. 2016. Molecular analysis of the

immunoglobulin genes in goose. Developmental and Comparative Immunology.

vol. 60. pp. 160-166.

Huang H, Wang F, Yang E, Wang H, Gao P, Shen H. 2018. Assessment of recombinant

plasmid expressing fusion antigen Ag85B-Rv3425 in management of acute

tuberculosis infection in mice. Experimental and Therapeutic Medicine. vol. 15.

no. 3. pp. 3034-3039.

Hutchison III CA. 2007. DNA sequencing: bench to bedside and beyond. Nucleic Acid

Research. vol. 35. no. 18. pp. 6227-6237.

Idexx. 2013. ELISA technical guide. IDEXX Laboratories Inc. USA. diakses 20

Desember 2017. https://www.idexx.eu/slovakia/education/articles/elisa-

technical-guide/

Jacob RF. 1994. Multiple-drug-resistant tuberculosis. Clinical Infectious Diseases. vol.

19. pp. 1-10.

Jacobs AJ, Mongkolsapaya J, Screaton GR, McShane H, Wilkinson RJ. 2016.

Antibodies and tuberculosis. Tuberculosis. vol. 101. pp. 102-113.



https://www.idexx.eu/slovakia/education/articles/elisa-technical-guide/https://www.idexx.eu/slovakia/education/articles/elisa-technical-guide/

159

Jensen EC. 2012. The basics of western blotting. The Anatomical Record. vol. 295. pp.

369-371.

Kaufmann SHE. 2004. New issues in tuberculosis. Annals of the Rheumatic Diseases.

vol. 63. no. 2. pp. 50-56.

Kefala G and Weiss MS. 2006. Cloning, expression, purification, crystallization and

preliminary X-ray diffraction analysis of DapA (Rv2753c) from Mycobacterium

tuberculosis. Acta Crystallization. vol. F62. no.11. pp. 1116-1119.

Kementerian Kesehatan RI Direktorat Jenderal Pengendalian Penyakit dan Penyehatan

Lingkungan. 2014. Pedoman nasional pengendalian tuberkulosis. Kementerian

Kesehatan RI. Jakarta. diakses 26 September 2015.

http://spiritia.or.id/dokumen/pedoman-tbnasional2014.pdf.

Kementerian Kesehatan RI (InfoDATIN: Pusat Data dan Informasi Kementerian

Kesehatan). 2016. Tuberkulosis temukan, obati sampai sembuh. PUSDATIN.

Jakarta. diakses 12 Januari 2017. www.depkes.go.id.

Kementerian Kesehatan RI. 2017. Data dan informasi profil kesehatan Indonesia 2016.

Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta. diakses 4 Januari

2018. http://www.depkes.go.id/resources/download/pusdatin/lain-

lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indo

nesia%202016%20-%20%20smaller%20size%20-%20web.pdf.

Kementerian Kesehatan RI (InfoDATIN: Pusat Data dan Informasi Kementerian

Kesehatan). 2018a. Tuberkulosis. PUSDATIN. Jakarta. diakses 4 Januari 2019.

www.depkes.go.id

Kementerian Kesehatan RI. 2018b. Data dan informasi profil kesehatan Indonesia

2017. Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta. diakses 4

November 2018

http://www.pusdatin.kemkes.go.id/resources/download/pusdatin/profil-

kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2017.pdf

Kim EJ, Kim EB, Lee SW, Cheon SA, Kim HJ, Lee J, Lee MK, Ko S, Park TJ. 2017.

An easy and sensitive sandwich assay for detection of Mycobacterium

tuberculosis Ag85B antigen using quantum dots and gold nanorods. Biosensors

and Bioelectronics. vol. 87. pp. 150-156.

Kitada S, Maekura R, Toyoshima N, Fujiwara N, Yano I, Ogura T, Ito M, Kobayashi

K. 2002. Serodiagnosis of pulmonary disease due to Mycobacterium avium

complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid

antigens. Clinical Infectious Diseases. vol. 35. no 11. pp. 1328–1335.



http://spiritia.or.id/dokumen/pedoman-tbnasional2014.pdfhttp://www.depkes.go.id/http://www.depkes.go.id/resources/download/pusdatin/lain-lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indonesia%202016%20-%20%20smaller%20size%20-%20web.pdfhttp://www.depkes.go.id/resources/download/pusdatin/lain-lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indonesia%202016%20-%20%20smaller%20size%20-%20web.pdfhttp://www.depkes.go.id/resources/download/pusdatin/lain-lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indonesia%202016%20-%20%20smaller%20size%20-%20web.pdfhttp://www.depkes.go.id/http://www.pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2017.pdfhttp://www.pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2017.pdf

160

Kitada S, Maekura R, Toyoshima N, Naka T, Fujiwara N, Kobayashi M, Yano I, Ito

M, Kobayashi K. 2005. Use of glycopeptidolipid core antigen for serodiagnosis of

Mycobacterium avium complex pulmonary disease in immunocompetent patients.

Clinical and Diagnostic Laboratory Immunology. vol. 12. no. 1. pp. 44-51.

Kitada S, Kobayashi K, Ichiyama S, Takakura S, Sakatani M, Suzuki K, Takashima T,

Nagai T, Sakurabayashi I, Ito M, Maekura R. 2008. Serodiagnosis of

Mycobacterium avium–complex pulmonary disease using an enzyme

immunoassay kit. American Journal of Respiratory and Critical Care Medicine.

vol. 177. no. 7. pp. 793–797.

Kitada S, Levin A, Hiserote M, Harbeck RJ, Czaja CA, Huitt G, Kasperbauer SH,

Daley CL. 2013. Serodiagnosis of Mycobacterium avium complex pulmonary

disease in the USA. European Respiratory Journal. vol. 42. no. 2. pp. 454–460.

Kitada S, Maekura R, Yoshimura K, Miki K, Miki M, Oshitani Y, Nishida K, Sawa N,

Mori M, Kobayashi K. 2017. Levels of antibody against glycopeptidolipid core as

a Marker for monitoring treatment response in Mycobacterium avium complex

pulmonary disease: a prospective cohort study. Journal Clinical Microbiology.

vol. 55. no. 3. pp. 884–892.

Korotkova N, Piton J, Wagner JM, Boy-Röttger S, Aleksandre J, Evans TJ, Cole ST,

Pojer F, Korotkov KV. 2015. Structure of EspB, a secreted substrate of the ESX-

1 secretion system of Mycobacterium tuberculosis. Journal of Structural Biology.

vol. 191. pp. 236-244.

Lande L, Alexander DC, Wallace RJ, Kwait RJ, Iakhiaeva E, Williams M, Cameron

ADS, Olshefsky S, Devon R, Vasireddy R, Peterson DD, Falkinham JO. 2019.

Mycobacterium avium in community and household water, suburban Philadelphia,

Pennsylvania, USA, 2010 – 2012. Emerging Infectious Diseases. vol. 25. no. 3.

pp. 473–481.

Larrea E, Riezu-Boj J-I, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A,

Gastaminza P, Civeira MP, Sarobe P, Prieto J. 2014. Dysregulation of interferon

regulatory factors impairs the expression of immunostimulatory molecules in

hepatitis C virus genotype 1-infected hepatocytes. Gut. vol. 63. no. 4. pp. 665-673.

Lee CD, Sun HC, Hu SM, Chiu CF, Homhuan A, Liang SM, Leng CH, Wang TF.

2008. An improved SUMO fusion protein system for effective production of

native proteins. Protein Science. vol. 17. pp. 1241-1248.

Lemeshow S, Hosmer DW, Klar J, Lwanga SK. 1990. Adequacy of sample size in

health studies. John Wiley & Sons Ltd. West Sussex.



161

Lin AV. 2015. Indirect ELISA. In: Hnasko R. (eds) ELISA. Methods in molecular

biology vol 1318. Humana Press. New York.

Liu Y, Zhang X, Zhang Y, Sun Y, Yao C, Wang W, Li C. 2018. Characterization of

Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility

phenotypes and Beijing genotype family transmission. BMC Infectious Diseases.

vol. 18. no. 1. pp. 658.

López-Varela E, García-Basteiro AL, Augusto OJ, Fraile O, Bulo H, Ira T, Gondo K,

van Ingen J, Naniche D, Sacarlal J, Alonso PL. 2017. Correction: high rates of

non-tuberculous mycobacteria isolation in Mozambican children with

presumptive tuberculosis. PLoS One. vol. 12. no. 1. pp. e0175613.

Lu Y, Xu Y, Yang E, Wang C, Wang H, Shen H. 2012. Novel recombinant BCG

coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular

immune and antibody responses in C57BL⁄6 Mice. Basic Immunology. vol. 76. no.

3. pp. 271-277.

Lundtoft C, Afum-Adjei Awuah A, Rimpler J, Harling K, Nausch N, Kohns M,

Adankwah E, Lang F, Olbrich L, Mayatepek E, Owusu-Dabo E, Jacobsen M.

2017. Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-

cell response to IL-7 in human tuberculosis. Plos Pathogens. vol. 13. no. 6. pp.

e1006425.

Lundtoft C, Afum-Adjei Awuah A, Güler A, Harling K, Schaal H, Mayatepek E,

Phillips RO, Nausch N, Owusu-Dabo E, Jacobsen M. 2018. An IL7RA exon 5

polymorphism is associated with impaired IL-7Rα splicing and protection against

tuberculosis in Ghana. Genes & Immunity. doi: 10.1038/s41435-018-0049-5.

Maekura R, Okuda Y, Nakagawa M, Hiraga T, Yokota S, Ito M, Yano I, Kohno H,

Wada M, Abe C, Toyoda T, Kishimoto T, Ogira T. 2001. Clinical Evaluation of

Anti-Tuberculous Glycolipid Immunoglobulin G Antibody Assay for Rapid

Serodiagnosis of Pulmonary Tuberculosis. Journal of Clinical Microbiolgy. vol.

39. no. 10. pp. 3603-3608

Mahboub BH and Vats MG. 2013. Tuberculosis-current issues in diagnosis and

management, InTech. Croatia. diakses 14 Maret 2016.

http://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-

management.

Mahmood T and Yang PC. 2012. Western blot: technique, theory, and trouble shooting.

North American Journal of Medical Science. vol. 4. no. 9. pp. 429-434.



http://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-managementhttp://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-management

162

Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. 2015. Multidrug

resistant tuberculosis: prevalence and risk factors in districts of metema and west

armachiho, Northwest Ethiopia. BMC Infectious Diseases. vol. 15. pp. 461.

Mertaniasih NM, Koendhori EB, Kusumaningrum D. 2013a. Tuberkulosis diagnostik

mikrobiologis. Airlangga University Press (AUP). Surabaya.

Mertaniasih NM, Wiqoyah N, Kuntaman, Wahyunitisari MR, Kusumaningrum D.

2013b. Polymerase chain reaction of Mycobacterium tuberculosis gyrb gene

region for rapid screening test of pulmonary tuberculosis. Folia Medica

Indonesiana. vol. 49. no. 1. pp. 16-20.

Mertaniasih NM, Kusumaningrum D, Koendhori EB, Soedarsono, Kusmiati T, Dewi

DNSS. 2017. Nontuberculous mycobacterial species and Mycobacterium

tuberculosis complex coinfection in patients with pulmonary tuberculosis in Dr.

Soetomo Hospital, Surabaya, Indonesia. The International Journal of

Mycobacteriology. vol. 6. no. 1. pp. 9-13.

Miltgen J, Morillon M, Koeck JL, Varnerot A, Briant JF, Nguyen G, Verrot D, Bonnet

D, Vincent V. 2002. Two cases of pulmonary tuberculosis caused by

Mycobacterium tuberculosis subsp. canetti. Emerging Infectious Diseases. vol. 8.

no. 11. pp. 1350-1352.

Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. 2015. Multidrug-

resistant Mycobacterium tuberculosis and associated risk factors in Oromia

Region of Ethiopia. International Journal of Infectious Diseases. vol. 39. pp. 57-

61.

Munshi A. 2012. DNA sequencing – methods and applications. InTech. Croatia.

Nagai S, Wiker HG, Harboe M, Kinomoto M. 1991. Isolation and partial

characterization of major protein antigens in the culture fluid of Mycobacterium

tuberculosis. Infection and Immunity. vol. 59. no. 1. pp. 372-382.

NCBI. 2016. esxA ESAT-6 protein EsxA [Mycobacterium tuberculosis H37Rv]. diakses

14 April 2016. https://www.ncbi.nlm.nih.gov/gene/886209.

NIAID. 2007. Research agenda multidrug resistant and extensively drug-resistant

tuberculosis. NIAID Tuberculosis Working Group. diakses 14 Maret 2016.

http://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearc

hagenda.pdf

Niki M, Suzukawa M, Akashi S, Nagai H, Ohta K, Inoue M, Niki M, Kaneko Y,

Morimoto K, Kurashima A, Kitada S, Matsumoto S, Suzuki K, Hoshino Y. 2015.

Evaluation of humoral immunity to Mycobacterium tuberculosis-specific antigens



https://www.ncbi.nlm.nih.gov/gene/886209http://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearchagenda.pdfhttp://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearchagenda.pdf

163

for correlation with clinical status and effective vaccine development. Journal of

Immunology Research. vol. 2015. ID 527395.

Nowakowski AB, Wobig WJ, Petering DH. 2014. Native SDS-PAGE: high resolution

electrophoretic separation of proteins with retention of native properties including

bound metal ions. Metallomics. vol. 6. no. 5. pp. 1068-1078.

Ogbo FA, Ogeleka P, Okoro A, Olusanya BO, Olusanya J, Ifegwu IK, Awosemo AO,

Eastwood J, Page A. 2018. Tuberculosis disease burden and attributable risk

factors in Nigeria, 1990–2016. Tropical Medicine and Health. vol. 46. pp. 34.

O’Gorman MRG and Donnenberg AD. 2008. Handbook of Human Immunology 2nd

edition. CRC Press (Taylor & Francis Group). USA.

Okkels LM and Andersen P. 2004. Protein-protein interactions of proteins from the

esat-6 family of Mycobacterium tuberculosis. Society. vol. 186. no. 8. pp. 2487-

2491.

Osada-Oka M, Tateishi Y, Hirayama Y, Ozeki Y, Niki M, Kitada S, Maekura R,

Tsujimura K, Koide Y, Ohara N, Yamamoto T, Kobayashi K, Matsumoto S. 2013.

Antigen 85A and mycobacterial DNA-binding protein 1 are targets of

immunoglobulin G in individuals with past tuberculosis. Microbiology

Immunology. vol. 57. pp. 30-37.

Owen JA, Punt J, Stranford SA. 2007. Kuby immunology 5th ed. W. H. Freeman and

Company. United States of America.

Owen JA, Punt J, Stranford SA. 2013. Kuby immunology 7h ed. W. H. Freeman and

Company. United States of America.

Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.

2007. The Ag85B protein of Mycobacterium tuberculosis may turn a protective

immune response induced by Ag85B-DNA vaccine into a potent but non-

protective Th 1 immune response in mice. Cellular Microbiology. vol. 9. no. 6.

pp. 1455-1465.

Parija SC. 2012. Textbook of microbiology & immunology 2nd edition. Reed Elsevier

India Private Limited. New Delhi.

Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, Bhattacharyya A, Kaisho T,

Kundu M, Basu J. 2007. Direct extracellular interaction between the early secreted

antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling

in macrophages. Nature Immunology. vol. 8. no. 6. pp. 610-618.



164

Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville

TO, Hossny E, Mazer B, Nelson R, Secord E, Jordan SC, Richard S, Vo AA,

Ballow M. 2017. Update on the use of immunoglobulin in human disease: A

review of evidence. Journal of Allergy and Clinical Immunology. vol. 139. no. 3.

pp. S1-S46.

Perumal R, Naidoo K, Padayatchi N. 2018. TB epidemiology: where are the young

women? Know your tuberculosis epidemic, know your response. BMC Public

Health. vol. 18. no. 1. pp. 417

Playfair JHL and Chain BM. 2012. At a glance imunologi edisi kesembilan. Erlangga.

Jakarta.

Prakash R, Kumar D, Gupta VK, Jain S, Chauhan DS, Tiwari PK, Katoch VM. 2016.

Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of

North Central India. Journal of Infection and Public Health. vol. 9. no. 3 pp. 289-

297.

Rane L, Rahman S, Magalhaes I, Ahmed R, Spangberg M, Kondova I, Verreck F,

Andersson J, Brighenti S, Maeurer MJ. 2011. Increased (6 exon) interleukin-7

production after M. tuberculosis infection and soluble interleukin-7 receptor

expression in lung tissue. Genes and Immunity. vol. 12. pp. 513-522.

Rashak HA, Sánchez-Pérez HJ, Abdelbary BE, Bencomo-Alerm A, Enriquez-Ríos N,

Gómez-Velasco A, Colorado A, Castellanos-Joya M, Rahbar MH, Restrepo BI.

2019. Diabetes, undernutrition, migration and indigenous communities:

tuberculosis in Chiapas, Mexico. Epidemiology and Infection. vol. 147. pp. e71.

Roy S and Kumar V. 2012. A Practical approach on SDS PAGE for separation of

protein. International Journal of Science and Research. vol. 3. no. 8. pp. 955-960.

Rodríguez-Ezpeleta N, Hackenberg M, Aransay AM. 2012. Bioinformatics for high

throughput sequencing. Springer Science+Business Media. New York.

Rogerson BJ, Jung YJ, LaCourse R, Ryan L, Enright N, North RJ. 2006. Expression

levels of Mycobacterium tuberculosis antigen-encoding genes versus production

levels of antigen-specific T cells during stationary level lung infection in mice.

Immunology. vol. 118. no. 2. pp. 195-201.

Rudolf F, Joaquim LC, Vieira C, Bjerregaard-Andersen M, Andersen A, Erlandsen M,

Sodemann M, Andersen PL, Wejse C. 2013. The Bandim tuberculosis score:

reliability and comparison with the Karnofsky performance score. Scandinavian

Journal of Infectious Diseases. vol. 45. pp. 256-264.



165

Rudolf F. 2014. The Bandim TBscore - reliability, further development, and evaluation

of potential uses. Global Health Action. vol. 7. pp. 24303.

Rudolf F, Wagner AJ, Back FM, Gomes VF, Aaby P, Østergaard L, Eugen-Olsen J,

Wejse C. 2017. Tuberculosis case finding and mortality prediction: added value

of the clinical TBscore and biomarker suPAR. The International Journal of

Tuberculosis and Lung Disease. vol. 21. no. 1. pp. 67-72.

Sagwa EL, Mantel-Teeuwisse AK, Ruswa NC. 2014. Occurrence and clinical

management of moderate-to-severe adverse events during drug-resistant

tuberculosis treatment: a retrospective cohort study, Journal of Pharmaceutical

Policy and Practice. vol. 7. no. 1. pp. 14.

Sambrook J and Russel DW. 2001. Molecular cloning, a laboratory manual, 3th

edition, volume 2. Cold Spring Harbor Laboratory Press. USA.

Sanger F. 1981. Sequences in DNA. Science. vol. 214. pp. 1205-1210.

Schluger NW. 2007. Tuberculosis and non-tuberculous mycobacterial infections in

older adults. Clinics in Chest Medicine. vol. 28. no. 4. pp. 773-781.

Schorey JS and Sweet L. 2008. The mycobacterial glycopeptidolipids: structure,

function, and their role in pathogenesis. Glycobiology. vol. 18. no. 11. pp. 832-

842.

Schroeder HW and Cavacini L. 2010. Structure and function of immunoglobulins.

Journal Allergy Clinical Immunology. vol. 125. no. 2. pp. 41-52.

Schuller M, Sloots TP, James GS, Halliday CL, Carter IWJ. 2010. PCR for clinical

microbiology an australian and international perspective. Springer

Science+Business Media. New York.

Sharma SK and Mohan A. 2004. Multidrug-resistant tuberculosis. Indian Journal

Medical Research. vol. 120. pp. 354-376.

Silva VMC, Kanaujia G, Gennaro ML, Menzies D. 2003. Factors associated with

humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of

tuberculosis. International Journal of Tuberculosis and Lung Disease. vol. 7. no.

5. pp. 478-484.

Simeone R, Bottai D, Frigui W, Majlessi L, Brosch R. 2015. ESX/type VII secretion

systems of mycobacteria: Insights into evolution, pathogenicity and protection.




166

Simonney B, Chavanet P, Perronne C, Leportier M, Revol F, Herrmann JL, Lagrange

PH. 2007. B-cell immune responses in HIV positive and HIV negative patients

with tuberculosis evaluated with an ELISA using a glycolipid antigen.


Singh S, Gopinath K, Shahdad S, Kaur M, Singh B, Sharma P. 2007. Nontuberculous

mycobacterial infection in Indian AIDS patients detected by a novel set of ESAT-

6 polymerase chain reaction primers. Japanese Journal of Infectious Disease. vol.

60. no. 1. pp.14-18.

Singleton P. 2000. DNA methods in clinical microbiology. Springer Science+Business

Media. Dordrecht.

Soedarsono. 2015. Asosiasi polimorfsme gen TLRs dengan derajat keparahan penyakit

pasien tb paru mdr dan peran sekuens gen esxA. Disertasi. Program Studi Ilmu

Kedokteran Jenjang Doktor. Fakultas Kedokteran Universitas Airlangga.

Soedarto. 2015. Mikrobiologi Kedokteran. Sagung Seto. Jakarta.

Solans L, Aguiló N, Samper S, Pawlik A, Frigui W, Martín C, Brosch R, Gonzalo-Asensio

J. 2014. A specific polymorphism in Mycobacterium tuberculosis H37Rv causes

differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 component.

Journal of Infection and Immunity. vol. 82. no. 8. pp. 3446-3456.

Steingart KR, Dendukuri N, Henry M, Schiller I, Nahid P, Hopewell PC, Ramsay A, Pai M,

Laal S. 2009. Performance of purified antigens for serodiagnosis of pulmonary

tuberculosis: a meta-analysis. Clinical and Vaccine Immunology. vol. 16. no. 2. pp. 260-

276.

Stevenson CR, Crithchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, Unwin

NC. 2007. Diabetes and the risk of tuberculosis: a neglected threat to public

health?. Chronic Illness. vol. 3. no. 3. pp. 228-245.

Sudre P, Dam GT, Kochi A. 1992. Tuberculosis: a global overview of the situation

today. Bulletin of The World Health Organization. vol. 70. no. 2. pp. 149-159.

Surkova L, Horevich HL, Titov LP, Sahalchyk E, Arjomandzadegan M, Alinejad S,

Sadrnia M. 2012. A study on demographic characteristics of drug resistant

Mycobacterium tuberculosis isolates in Belarus. International Journal of

Mycobacteriology. vol. I. no. 2. pp. 75-81.

Takei F and Nakatani K. 2013. The chemistry of pcr primers: concept and application.

Israel Journal of Chemistry. vol. 53. pp. 1-16.



167

Tan Y, Su B, Shu W, Cai X, Kuang S, Kuang H, Liu J, Pang Y. 2018. Epidemiology

of pulmonary disease due to nontuberculous mycobacteria in Southern China,

2013–2016. BMC Pulmonary Medicine. vol. 18. pp. 168.

Taniguchi K, Takii T, Yamamoto S, Maeyama JI, Iho S, Maruyama M, Iizuka N, Ozeki

Y, Matsumoto S, Hasegawa T, Miyatake Y, Itoh S, Onozaki K. 2013. Reactivation

of immune responses against Mycobacterium tuberculosis by boosting with the

CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG.

Immunity & Ageing. vol. 10. pp. 25.

Tape TG. 2000. Using the receiver operating characteristic (ROC) curve to analyze a

classification model. University of Nebraska Medical Center. diakses 19 Oktober

2018. http://gim.unmc.edu/dxtests/effect1.htm.

Tasbiti AH, Yari S, Ghanei M, Shokrgozar MA, Fateh A, Bahrmand A. 2017. Low

level of extensively drug-resistant tuberculosis among MDR-TB isolates and its

relationship to risk factors: surveillance in Tehran-Iran. Osong Public Health

Research Perspective. vol. 8. no. 2. pp. 116-123.

TB Database. 2010. Rv3875-6 kda early secretory antigenic target esxA. diakses 14

April 2016. http://genome.tbdb.org/cgi-bin/GeneDetails.html?id=SRv3875.

Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof GM. 2017. Association

between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a

systematic review and meta-analysis. Systematic Reviews. vol. 2017. no. 6. pp. 1-

5.

Terrazzini N, Mantegani P, Kern F, Fortis C, Mondino A, Caserta S. 2018. Interleukin-

7 unveils pathogen-specific T Cells by enhancing antigen-recall responses.

Journal of Infectious Diseases. vol. 217. no 12. pp. 1997-2007.

Teutschbein J, Schumann G, Möllmann U, Grabley S, Cole ST, Munder T. 2009. A

protein linkage map of the ESAT-6 secretion system 1(ESX-1) of Mycobacterium

tuberculosis. Microbiological Resarch. vol. 164. pp. 253-259.

Thang PH, Ruffin N, Brodin D, Rethi B, Cam PD, Hien NT, Lopalco L, Vivar N,

Chiodi F. 2010. The role of IL-1β in reduced IL-7 production by stromal and

epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1

infection. Journal of Internal Medicine. vol. 268. no. 2. pp. 181-193.

Tille PM. 2014. Bailey & scott’s diagnostic microbilogy 13th edition. Elsevier Mosby.

Missouri.

Tipu HN and Shabbir A. 2015. Evolution of DNA sequencing. Journal of the College

of Physicians and Surgeons Pakistan. vol. 25. no. 3. pp. 210-215.



http://gim.unmc.edu/dxtests/effect1.htmhttp://genome.tbdb.org/cgi-bin/GeneDetails.html?id=SRv3875

168

Todar K. 2012 Mycobacterium tuberculosis and tuberculosis. diakses 25 Maret 2016.

http://textbookofbacteriology.net/tuberculosis.html

Tuberculist. 2013. fbpB. diakses 28 Maret 2018.

http://svitsrv8.epfl.ch/tuberculist/quicksearch.php?gene+name=fbpB&submit=Se

arch

Tullius MV, Harth G, Masleša-Galić S, Dillon BJ, Horwitz MA. A replication-limited

recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for

human immunodeficiency virus-positive persons is safer and more efficacious

than BCG. Infection and Immunity. vol. 76, no. 11. pp. 5200-5214.

Turner RD and Bothamley GH. 2015. Cough and the transmission of tuberculosis. The

Journal of Infectious Diseases. vol. 211. no. 9. pp. 1367-1372.

Ugarte-Gil C, Alisjahbana B, Ronacher K, Riza AL, Koesoemadinata RC, Malherbe

ST, Cioboata R, Llontop JC, Kleynhans L, Lopez S, Santoso P, Marius C,

Villaizan K, Ruslami R, Walzl G, Panduru NM, Dockrell HM, Hill PC, Mc

Allister S, Pearson F, Moore DAJ, Critchley JA, van Crevel R. 2019. Diabetes

mellitus among pulmonary tuberculosis patients from four TB-endemic countries:

the TANDEM study. Clinical Infectious Diseases. ciz284. doi:

10.1093/cid/ciz284.

Uplekar S, Heym B, Friocourt V, Rougemont J, Cole ST. 2011. Comparative genomics

of esx genes from clinical isolates of Mycobacterium tuberculosis provides

evidence for gene conversion and epitope variation. Journal Infection and

Immunity. vol. 79. no. 10. pp. 4042-4049.

van Crevel R, Ottenhoff THM and van der Meer JWM. 2002. Innate immunity to

Mycobacterium tuberculosis. Clinical Microbiology Reviews. vol. 15. no. 2. pp.

294-309.

Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, Petersen E, Wejse C,

2014. Treatment delay affects clinical severity of tuberculosis: a longitudinal

cohort study. BMJ Open. vol. 4. pp. e004818.

Wakabayashi K. 2010. ELISA- A to Z from introduction to practice. Shibayagi Co Ltd.

Jepang.

Walker JM. 2002. Protein protocols handbook second edition. Humana Press Inc.

United States of America.



http://textbookofbacteriology.net/tuberculosis.htmlhttp://svitsrv8.epfl.ch/tuberculist/quicksearch.php?gene+name=fbpB&submit=Searchhttp://svitsrv8.epfl.ch/tuberculist/quicksearch.php?gene+name=fbpB&submit=Searchhttps://doi.org/10.1093/cid/ciz284https://doi.org/10.1093/cid/ciz284

169

Weber K and Osborn M. 1969. The reliability of molecular weight determinations by

dodecyl sulfate-polyacrylamide gel electrophoresis. The Journal of Biological

Chemistry. vol. 244. no. 16. pp. 4406-4412.

WHO. 2010. Multidrug and extensively drug-resistant tb (m/xdr-tb) 2010 global

report on surveillance and response. World Health Organization. Geneva.

diakses tanggal 14 Maret 2016.

http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdf.

WHO. 2014. Global tuberculosis report 2014. World Health Organization. Geneva.

diakses 14 Januari 2016. http://www.who.int/tb/country/en/.

WHO. 2015a. Implementation tuberculosis diagnostics. World Health Organization.

Geneva. diakses 17 Juni 2016.

http://apps.who.int/iris/bitstream/10665/162712/1/9789241508612_eng.pdf

WHO. 2015b. Tuberculosis control in the South-East Asia region. World Health

Organization. Geneva. diakses 1 Desember 2015.

http://www.searo.who.int/tb/annual-tb-report-2015.pdf.

WHO. 2015c. Global tuberculosis report 2015. World Health Organization. Geneva.

diakses 1 Desember 2015.

http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=

1.

WHO. 2016a. Global tuberculosis report 2016. World Health Organization. Geneva.

diakses 12 Januari 2017.

http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1

WHO. 2016b. Tuberculosis control in the South-East Asia Region. World Health

Organization. Geneva. diakses 4 Januari 2018.

http://apps.who.int/iris/handle/10665/205286

WHO. 2016c. WHO treatment guidelines for drug-resistant tuberculosis. World Health

Organization. Geneva. diakses 26 September 2016.

http://www.who.int/tb/MDRTBguidelines2016.pdf.


diakses 7 Desember 2017.

http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1


diakses 30 September 2018.

https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-

eng.pdf?ua=1



http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdfhttp://www.who.int/tb/country/en/http://apps.who.int/iris/bitstream/10665/162712/1/9789241508612_eng.pdfhttp://www.searo.who.int/tb/annual-tb-report-2015.pdfhttp://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1http://apps.who.int/iris/handle/10665/205286http://www.who.int/tb/MDRTBguidelines2016.pdfhttp://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1

170

Yang H, Kruh-Garcia NA, Dobos KM. 2012. Purified Protein Derivatives of

Tuberculin - Past, Present, and Future. Medical Microbiology and Immunology.

vol. 66. no. 3. pp. 273-280.

You E, Kim M, Lee WI, Kang SY. 2016. Evaluation of IL-2, IL-10, IL-17 and IP-10

as potent discriminative markers for active tuberculosis among pulmonary

tuberculosis suspects. Tuberculosis. vol. 99. pp. 100-108.

Yu X and Xie J. 2012. Roles and underlying mechanisms of ESAT-6 in the context of

Mycobacterium tuberculosis–host interaction from a systems biology perspective.

Cellular Signalling. vol. 24. pp. 1841-1846.

Zhang W, Shu Q, Zhao Z, Fan J, Lyon CJ, Zelazny AM, Hu Y. 2018. Antigen 85B

peptidomic analysis allows species-specific mycobacterial identification. Clinical

Proteomics. vol. 15. pp. 1.

Zhang CY, Zhao F, Xia YY, Yu YL, Shen X, Lu W, Wang XM, Xing J, Ye JJ, Li JW,

Liu FY, Wu JL, Xu L, Zhang H, Cheng J, Wang LX. 2019. Prevalence and risk

factors of active pulmonary tuberculosis among elderly people in China: a

population based cross-sectional study. Infectious Diseases of Poverty. vol. 8.

no.1. pp. 7.

Zhao J, Shiratori B, Okumura M, Yanai H, Matsumoto M, Nakajima C, Mizuno K,

Ono K, Oda T, Chagan-Yasutan H, Ashino Y, Matsuba T, Yoshiyama T, Suzuki

Y, Hattori T. 2017a. Difference in antibody responses to mycobacterium

tuberculosis antigens in japanese tuberculosis patients infected with the

beijing/non-beijing genotype. Journal of Immunology Research. vol. 2017. pp.

4797856.

Zhao J, Matsuba T, Zhang X, Leano S, Nakajima C, Chagan-Yasutan H, Telan EF,

Suzuki Y, Hattori T. 2017b. Comparison of antibody responses against

Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the

endemic and non-endemic regions of the Beijing genotype: a case control study.

BMC Infectious Diseasess. vol. 14. pp. 344.



Sampul DepanSampul DalamHalaman Prasyarat Gelar DoktorLembar PengesahanPenetapan Panitia PengujiUCAPAN TERIMA KASIHRINGKASANSUMMARYABSTRACTDAFTAR ISIDAFTAR TABELDAFTAR GAMBARDAFTAR LAMPIRANDAFTAR SINGKATANBAB 1 PENDAHULUANBAB 2 TINJAUAN PUSTAKABAB 3 KERANGKA KONSEP DAN HIPOTESIS PENELITIANBAB 4 METODE PENELITIANBAB 5 ANALISIS HASIL PENELITIANBAB 6 PEMBAHASANBAB 7 PENUTUPDAFTAR PUSTAKALAMPIRAN

daftar pustakarepository.unair.ac.id/86878/3/dis. k. 26-19 dew p daftar...152 daftar pustaka abebe...

Documents